Delivery Order SPE2DB20D3103-SPE2DB25FM8D5
Award Date
2/24/25
Potential Completion Date
2/25/25
Potential Value
$2.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,002.68, is a Firm Fixed Price Delivery Order for the supply of VISIPAQUE 320 MG/ML BOTTLE 100ML, a pharmaceutical product. The contract has an ultimate completion date of January 15, 2025 and was awarded on January 14, 2025. The contract is not designated as a set-aside. In addition to this...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order valued at $1,687.64 with a firm fixed price and an ultimate completion date of November 20, 2024. The contract is for the supply of VISIPAQUE 320 MG/ML INFUS BTL 150ML, a pharmaceutical product. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,796.88 firm-fixed-price delivery order is for the supply of VISIPAQUE 320 MG/ML BOTTLE 100ML, a medical product. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,845.73 Firm Fixed Price Delivery Order is for the supply of VISIPAQUE 320 MG/ML BOTTLE 100ML, a medical product, to support military treatment facilities and programs. The contract has an ultimate completion date of August 15, 2024 and was awarded on August 14, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between...
This federal contract award, with ID SPE2DB22D2206|SPE2DB25FEN60, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,171.42 firm-fixed-price delivery order is for the supply of VISIPAQUE 320 MG/ML BOTTLE 100ML, a medical product, with a performance period ending on December 6, 2024. This contract award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 4, 2024. The $1,687.64 Firm Fixed Price contract is for the delivery of VISIPAQUE 320 MG/ML INFUS BTL 150ML, a medical product, to support DLA operations. This award is issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC...
This federal contract award is for the delivery of VISIPAQUE 320 MG/ML INFUS BTL 150ML pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The $2,615.78 firm fixed price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 26, 2024 with a completion date of August 27, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA valued at up to $999,999,999 through December 2025...
This federal contract award is for the delivery of VISIPAQUE 320 MG/ML INFUS BTL 150ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,687.64, was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems. The award is a delivery order placed under...
This federal contract award is for the delivery of VISIPAQUE 320 MG/ML BOTTLE 100ML, a medical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on November 20, 2024 with a ceiling value of $3,763.78. The contract has a firm fixed price pricing type and an ultimate completion date of November 21, 2024. This is a delivery order contract and is not associated with a...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation, for the supply of VISIPAQUE 320 MG/ML INFUS BTL 150ML medical products. The $5,906.74 award has a completion date of February 2, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 2025, which serves as the primary...